ClinicalTrials.gg
Sign In

Malaria, Vivax clinical trials

The registry lists 123 studies for Malaria, Vivax across more than 10 countries. 19 are recruiting or about to start. 95 of them are mainly about Malaria, Vivax (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22.

Get an email when these change. Save the Malaria, Vivax studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
81
Not yet recruiting
10
Terminated
9
Recruiting
9
Status unknown
7
Withdrawn
5

Phase

Phase 2
28
Phase 4
24
Phase 3
22
Phase 1
18
Early Phase 1
3

Where

Thailand
21
Brazil
14
Indonesia
14
Ethiopia
13
Papua New Guinea
10
Vietnam
8

Who runs them

University of Oxford (23) · Menzies School of Health Research (11) · GlaxoSmithKline (9) · Medicines for Malaria Venture (5) · Malaria Vaccine and Drug Development Center (5) · London School of Hygiene and Tropical Medicine (5) · Centers for Disease Control and Prevention (4) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (4)

What is being tested here

Drugs under test in Malaria, Vivax studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tafenoquine8619
Chloroquine3319
Primaquine2726
Artenimol139
Piperaquine139
SJ733102
Artemether102
Artesunate012
Artefenomel002
Lumefantrine001

Coming up

6phase 3 studies under way
9studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 9 Malaria, Vivax studies recruiting now, 6 (67%) set no upper age limit and 3 (33%) stop at 75 or younger. 5 (56%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (22%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
105 (56%)5 (56%)
188 (89%)8 (89%)
308 (89%)8 (89%)
408 (89%)8 (89%)
508 (89%)8 (89%)
657 (78%)7 (78%)
756 (67%)6 (67%)
856 (67%)6 (67%)

Across all 123 studies, recruiting or not: 42% stop at 75 or younger and 38% at 65; 59% take children; 5% are for women only and 2% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Malaria, Vivax studies take

Of 14 interventional studies with no phase under Malaria, Vivax, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase26 mo16–56 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 123. Browse all 123 → or search them.